An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer
一项开放标签研究，评估皮下注射 CpG 寡脱氧核苷酸 (PF03512676) 联合曲妥珠单抗治疗转移性 HER2+ 乳腺癌患者的疗效
期刊:Cancer Control
影响因子:2.6
doi:10.1177/10732748241250189
Quiroga, Dionisia; Wesolowski, Robert; Zelinskas, Sara; Pinette, Ashley; Benner, Brooke; Schwarz, Emily; Savardekar, Himanshu; Johnson, Courtney; Stiff, Andrew; Yu, Lianbo; Macrae, Erin; Lustberg, Maryam; Mrozek, Ewa; Ramaswamy, Bhuvaneswari; Carson, William E 3rd
